CMH Wealth Management LLC Purchases 4,575 Shares of Synopsys, Inc. $SNPS

CMH Wealth Management LLC increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 42.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,299 shares of the semiconductor company’s stock after buying an additional 4,575 shares during the period. Synopsys accounts for approximately 1.6% of CMH Wealth Management LLC’s holdings, making the stock its 28th biggest position. CMH Wealth Management LLC’s holdings in Synopsys were worth $7,548,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Symphony Financial Ltd. Co. grew its stake in shares of Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after acquiring an additional 39,395 shares during the last quarter. HBW Advisory Services LLC raised its stake in Synopsys by 494.9% during the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Synopsys by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the period. Westbourne Investments Inc. acquired a new stake in Synopsys in the 2nd quarter worth $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Synopsys by 1.7% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after purchasing an additional 2,991 shares during the period. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Performance

Synopsys stock opened at $469.72 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a fifty day moving average price of $438.98 and a two-hundred day moving average price of $503.01. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The firm has a market capitalization of $89.87 billion, a P/E ratio of 58.79, a P/E/G ratio of 3.91 and a beta of 1.12.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the company earned $3.40 EPS. The firm’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Activity

In other news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.62% of the company’s stock.

Analyst Ratings Changes

SNPS has been the subject of several research reports. The Goldman Sachs Group reduced their target price on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. JPMorgan Chase & Co. raised their target price on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Finally, BNP Paribas started coverage on shares of Synopsys in a research note on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price objective for the company. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Synopsys currently has a consensus rating of “Moderate Buy” and a consensus price target of $562.13.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.